Stay updated with breaking news from Augmented Intelligence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The COVID-19 pandemic has irrevocably expedited adoption of enterprise augmented and artificial intelligence (collectively AI) solutions in...
/PRNewswire/ -- The COVID-19 pandemic has irrevocably expedited adoption of enterprise augmented and artificial intelligence (collectively AI) solutions in...
New Chilmark Research report on artificial intelligence (AI) for healthcare operations forecasts a market poised for explosive growth...
/PRNewswire/ -- CDL 1000 CEO and co-founder Andrew Sobko joined the conversation at the 10th anniversary of the World Leaders Forum hosted at Judson University...
Dapagliflozin, a drug commonly used to treat type 2 diabetes, improved symptoms and physical limitations in patients with heart failure with preserved ejection fraction, according to clinical trial results published in Nature Medicine.